A detailed history of Vanguard Group Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 790,136 shares of ANIK stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
790,136
Previous 773,702 2.12%
Holding current value
$19.4 Million
Previous $19.7 Million 1.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$24.57 - $28.47 $403,783 - $467,875
16,434 Added 2.12%
790,136 $20 Million
Q1 2024

May 10, 2024

BUY
$21.95 - $26.42 $211,971 - $255,137
9,657 Added 1.26%
773,702 $19.7 Million
Q4 2023

Feb 14, 2024

SELL
$18.47 - $23.3 $69,299 - $87,421
-3,752 Reduced 0.49%
764,045 $17.3 Million
Q3 2023

Nov 14, 2023

SELL
$16.98 - $26.1 $3.28 Million - $5.03 Million
-192,909 Reduced 20.08%
767,797 $14.3 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $28.86 $540,864 - $620,403
-21,497 Reduced 2.19%
960,706 $25 Million
Q1 2023

May 15, 2023

SELL
$25.91 - $32.1 $40,549 - $50,236
-1,565 Reduced 0.16%
982,203 $28.2 Million
Q4 2022

Feb 10, 2023

SELL
$23.85 - $31.91 $85,860 - $114,876
-3,600 Reduced 0.36%
983,768 $29.1 Million
Q3 2022

Nov 14, 2022

BUY
$21.74 - $24.68 $263,597 - $299,245
12,125 Added 1.24%
987,368 $23.5 Million
Q2 2022

Aug 12, 2022

SELL
$20.4 - $25.53 $209,140 - $261,733
-10,252 Reduced 1.04%
975,243 $21.8 Million
Q1 2022

May 13, 2022

BUY
$24.7 - $36.54 $483,675 - $715,526
19,582 Added 2.03%
985,495 $24.7 Million
Q4 2021

Feb 14, 2022

BUY
$35.83 - $45.03 $484,959 - $609,481
13,535 Added 1.42%
965,913 $34.6 Million
Q3 2021

Nov 12, 2021

SELL
$38.75 - $44.47 $206,266 - $236,713
-5,323 Reduced 0.56%
952,378 $40.5 Million
Q2 2021

Aug 13, 2021

BUY
$39.42 - $48.08 $37.8 Million - $46 Million
957,701 New
957,701 $41.5 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.